{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:20:48Z","timestamp":1790961648694,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1097\/01.ju.0000113299.34404.22","type":"journal-article","created":{"date-parts":[[2004,8,25]],"date-time":"2004-08-25T22:26:49Z","timestamp":1093472809000},"page":"1098-1104","source":"Crossref","is-referenced-by-count":200,"title":["High Dose Rate Brachytherapy as Prostate Cancer Monotherapy Reduces Toxicity Compared to Low Dose Rate Palladium Seeds"],"prefix":"10.1097","volume":"171","author":[{"given":"INGA S.","family":"GRILLS","sequence":"first","affiliation":[{"name":"From the Department of Radiation Oncology (ISG, AAM, GSG), Department of Urology (MH, KG) and Research Institute Biostatistics (RH), William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALVARO A.","family":"MARTINEZ","sequence":"additional","affiliation":[{"name":"From the Department of Radiation Oncology (ISG, AAM, GSG), Department of Urology (MH, KG) and Research Institute Biostatistics (RH), William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MITCHELL","family":"HOLLANDER","sequence":"additional","affiliation":[{"name":"From the Department of Radiation Oncology (ISG, AAM, GSG), Department of Urology (MH, KG) and Research Institute Biostatistics (RH), William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAYWIN","family":"HUANG","sequence":"additional","affiliation":[{"name":"From the Department of Radiation Oncology (ISG, AAM, GSG), Department of Urology (MH, KG) and Research Institute Biostatistics (RH), William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KENNETH","family":"GOLDMAN","sequence":"additional","affiliation":[{"name":"From the Department of Radiation Oncology (ISG, AAM, GSG), Department of Urology (MH, KG) and Research Institute Biostatistics (RH), William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER Y.","family":"CHEN","sequence":"additional","affiliation":[{"name":"From the Department of Radiation Oncology (ISG, AAM, GSG), Department of Urology (MH, KG) and Research Institute Biostatistics (RH), William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GARY S.","family":"GUSTAFSON","sequence":"additional","affiliation":[{"name":"From the Department of Radiation Oncology (ISG, AAM, GSG), Department of Urology (MH, KG) and Research Institute Biostatistics (RH), William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1097\/01.ju.0000113299.34404.22_bib1","first-page":"78","article-title":"External beam radiotherapy versus radical prostatectomy for clinical stage T1\u20132 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores","volume":"3","author":"Kupelian","year":"1997","journal-title":"Cancer J Sci Am"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z","article-title":"A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged and treated at a single institution","volume":"88","author":"Martinez","year":"2000","journal-title":"Cancer"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0360-3016(99)00499-X","article-title":"Palladium-103 brachytherapy for prostate carcinoma","volume":"46","author":"Blasko","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00006-6","article-title":"A dose-response study for I-125 prostate implants","volume":"41","author":"Stock","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00130404-200201000-00012","article-title":"I-125 versus Pd-103 for low risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial","volume":"8","author":"Wallner","year":"2002","journal-title":"Cancer J"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0360-3016(96)00609-8","article-title":"Biochemical disease-free survival following 125I prostate implantation","volume":"37","author":"Beyer","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(00)01463-2","article-title":"Phase II prospective study of the use of conformal high-dose rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report","volume":"49","author":"Martinez","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0360-3016(99)00499-X","article-title":"Palladium-103 brachytherapy for prostate carcinoma","volume":"46","author":"Blasko","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0360-3016(93)90546-8","article-title":"Concurrent treatment planning for outpatient high dose rate prostate template implants","volume":"27","author":"Edmundson","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(95)00276-6","article-title":"Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy","volume":"33","author":"Edmundson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib12","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0360-3016(01)01616-9","article-title":"Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society","volume":"51","author":"Nag","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl.","key":"10.1097\/01.ju.0000113299.34404.22_bib14","first-page":"113","article-title":"Transperineal ultrasound-guided implantation of the prostate: morbidity and complications","volume":"137","author":"Blasko","year":"1991","journal-title":"Scand J Urol Nephrol"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1999.17.2.517","article-title":"Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer","volume":"17","author":"Zelefsky","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0360-3016(00)00550-2","article-title":"Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer","volume":"47","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0360-3016(01)02811-5","article-title":"Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy","volume":"53","author":"Kang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0360-3016(00)00632-5","article-title":"Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer","volume":"48","author":"Gelbaum","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(98)00486-6","article-title":"Rectal dosimetric analysis following prostate brachytherapy","volume":"43","author":"Merrick","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","article-title":"Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy","volume":"32","author":"Wallner","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000113299.34404.22_bib13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/01.ju.0000052720.62999.a9","article-title":"Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors","volume":"169","author":"Martinez","year":"2003","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705624226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705624226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1097\/01.ju.0000113299.34404.22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:24:12Z","timestamp":1651213452000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1097\/01.ju.0000113299.34404.22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1097\/01.ju.0000113299.34404.22"],"URL":"https:\/\/doi.org\/10.1097\/01.ju.0000113299.34404.22","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}